News | September 19, 2025
Merck opens €150 million manufacturing facility in Ireland
Merck opens first climate-neutral manufacturing facility in Ireland
Merck opens first climate-neutral manufacturing facility in Ireland
Encouraging early detection and breaking the silence around men’s health
The new subcutaneous autoinjector for lecanemab offers a self-administered, at-home treatment option for early-stage Alzheimer's disease
The updated formula for Spikevax is now approved for individuals 6 months through 64 years of age
VYVGART was well tolerated, with a safety profile consistent with prior studies in AChR-Ab seropositive gMG and other indications
Collaboration reinforces Boehringer Ingelheim’s expertise in microbial contract development and manufacturing
AINU is set to accelerate its expansion footprint, enhance operational capabilities
The submission is supported by results from the Phase 3b APEX study
For patients with resectable early-stage gastric and gastroesophageal junction cancers
The new facility will be the company’s fourth spinning plant for hollow-fiber cellulose membrane filters
Subscribe To Our Newsletter & Stay Updated
